Mar 16, 2022 / 07:20PM GMT
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior Analyst
Great. Well, good afternoon, and welcome to the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays. And as we enter the afternoon, we're very pleased to welcome Alector to the stage.
Joining us from the company is Co-Founder, CEO, Arnon Rosenthal. Arnon, thank you very much for joining us. I know it's a busy time for the company. You guys had data at AD/PD host -- had a call yesterday on that. I think the presentation was today or -- I think that's right. So I know a busy time for you. Thanks for taking the time out to speak with us today.
Arnon Rosenthal - Alector, Inc. - Co-Founder, CEO & Director
Yes. Thank you for the invitation, and thank you, everyone, for joining this (inaudible).
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior Analyst
Perfect. So maybe before we jump into Q&A, I think it would be helpful to give a little background of the company
Alector Inc at Barclays Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
